| Code | Display |
| 100000116046 |
Full application (Article 8(3) of Directive No 2001/83/EC) |
| 100000116047 |
New active substance (Article 8(3) of Directive No 2001/83/EC) |
| 100000116048 |
Known active substance (Article 8(3) of Directive No 2001/83/EC) |
| 100000116049 |
Generic, hybrid or similar biological application (Article 10 of Directive No 2001/83/EC) |
| 100000116050 |
Generic application (Article 10(1) of Directive No 2001/83/EC) |
| 100000116051 |
Hybrid application (Article 10(3) of Directive No 2001/83/EC) |
| 100000116052 |
Similar biological application (Article 10(4) of Directive No 2001/83/EC) |
| 100000116053 |
Well-established use application (Article 10a of Directive No 2001/83/EC) |
| 100000116054 |
Fixed combination application (Article 10b of Directive No 2001/83/EC) |
| 100000116055 |
Informed consent application (Article 10c of Directive No 2001/83/EC) |
| 100000116056 |
Traditional use registration for herbal medicinal product application (Article 16a of Directive No 2001/83/EC) |
| 100000116057 |
Full application (Article 12(3) of Directive No 2001/82/EC) |
| 100000116058 |
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC) |
| 100000116059 |
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC) |
| 100000116060 |
Generic, hybrid or similar biological application (Article 13 of Directive No 2001/82/EC) |
| 100000116061 |
Generic application (Article 13(1) of Directive No 2001/82/EC) |
| 100000116062 |
Hybrid application (Article 13(3) of Directive No 2001/82/EC) |
| 100000116063 |
Similar biological application (Article 13(4) of Directive No 2001/82/EC) |
| 100000116064 |
Well-established use application (Article 13a of Directive No 2001/82/EC) |
| 100000116065 |
Fixed combination application (Article 13b of Directive No 2001/82/EC) |
| 100000116066 |
Informed consent application (Article 13c of Directive No 2001/82/EC) |
| 100000116067 |
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC) |
| 100000116068 |
Ancillary medicinal substance/blood derivative substance (Article 1(4) of both Directives No 93/42/EEC and 90/385/EEC) |
| 100000116069 |
Bibliographical application (stand-alone) |
| 100000116070 |
Informed consent (abridged application) - Council Directive 81/851/EEC |
| 100000116071 |
Fixed combination |
| 100000116072 |
Complete application (stand-alone) |
| 100000116073 |
Complete mixed application |
| 100000116074 |
Generic (abridged application) - art 10(1) |
| 100000116075 |
Last paragraph (abridged application) |
| 100000116076 |
Complete application (stand-alone) - Annex of Council Regulation (EEC) No 2309/93 |
| 100000116077 |
Complete application (stand-alone) - Directive No 2001/82/EC |
| 100000116078 |
Generic (abridged application) - art 13(1) |
| 100000116079 |
Informed consent (abridged application) - art 10c |
| 100000116080 |
Complete application (stand-alone) - Council Directive 81/851/EEC |
| 100000116081 |
Article 58 of Regulation (EC) No 726/2004 |
| 100000116082 |
Informed consent (abridged application) - Council Regulation 2001/82/EC |
| 200000013166 |
Known human blood/plasma derived ancillary medicinal substance (Article 52 (9) of Regulation (EU) 2017/745) |
| 200000013167 |
Known ancillary medicinal substance (not human blood/plasma derived) (Article 52 (9) of Regulation (EU) 2017/745) |
| 200000013168 |
Unknown human blood/plasma derived ancillary medicinal substance (Article 52 (9) of Regulation (EU) 2017/745) |
| 200000013169 |
Unknown ancillary medicinal substance (not human blood/plasma derived) (Article 52 (9) of Regulation (EU) 2017/745) |
| 200000013170 |
Companion Diagnostics (Article 48 (3), (4), (7), (8) of Regulation (EU) 2017/746) |
| 200000013171 |
Medical device composed of a substance or combinations of substances (Article 52 (11) of Regulation (EU) 2017/745) |
| 200000013173 |
Registered homeopathic medicinal products (Article 17 of Directive No 2001/82/EC) |
| 200000013174 |
Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC) |
| 200000013175 |
Legal basis not covered by Directive 2001/82/EC |
| 200000013176 |
Authorisations for temporary use (article 8 of Directive No 2001/82/EC) |
| 200000013177 |
Legal basis reviewed according to Acquis communautaire |
| 200000013178 |
Full application - new active substance (Article 8 of Regulation (EU) 2019/6) |
| 200000013179 |
Full application - known active substance (Article 8 of Regulation (EU) 2019/6) |
| 200000013180 |
Generic application (Article 18 of Regulation (EU) 2019/6) |
| 200000013181 |
Hybrid application - change in active substance(s) (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000013182 |
Combination veterinary medicinal products (Article 20 of Regulation (EU) 2019/6) |
| 200000013183 |
Informed Consent application (Article 21 of Regulation (EU) 2019/6) |
| 200000013184 |
Bibliographic application (Article 22 of Regulation (EU) 2019/6) |
| 200000013185 |
Applications for limited markets (Article 23 of Regulation (EU) 2019/6) |
| 200000013186 |
Applications in exceptional circumstances (Article 25 of Regulation (EU) 2019/6) |
| 200000013187 |
Registered homeopathic veterinary medicinal products (Article 86 of Regulation (EU) 2019/6) |
| 200000013188 |
Permission for national use due to health situation (Article 116 of Regulation (EU) 2019/6) |
| 200000013189 |
Authorised homeopathic medicinal products (Article 85(2) of Regulation (EU) 2019/6) |
| 200000013906 |
Veterinary medicinal products intended for animals exclusively kept as pets (article 5(6) of Reg 2019/6) |
| 200000013907 |
Parallel traded products as referred to in article 102 of Regulation 2019/6 |
| 200000016435 |
Hybrid application - change in therapeutic indication(s) (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000016436 |
Hybrid application - change in strength (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000016437 |
Hybrid application - change in route of administration (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000016438 |
Hybrid application - change in pharmaceutical form (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000016439 |
Hybrid application - bioavailability studies cannot be used to demonstrate bioequivalence (Article 19(1)(b) of Regulation (EU) 2019/6) |
| 200000016440 |
Hybrid application - differences in raw materials or in manufacturing processes of biological VMPs (Article 19(1)(c) of Regulation (EU) 2019/6) |
| 200000016456 |
Simplified registration application for a homeopathic medicinal product (Article 14 of Directive No 2001/83/EC) |
| 200000016457 |
Medicinal product authorised according to Article 126a of Directive No 2001/83/EC |
| 200000022794 |
Simplified registration application for a homeopathic veterinary medicinal product (Article 17 of Directive No 2001/82/EC) |
| 200000023331 |
Authorisation according to Article 5(1) of Directive 2001/83/EC |
| 200000023341 |
Authorisation according to Article 5(2) of Directive 2001/83/EC |
| 200000023342 |
Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC |
| 200000023343 |
Parallel importation notified in accordance with Article 76(4) of Directive 2001/83/EC |
| 200000023344 |
Available under Article 83(2) of Regulation (EC) No 726/2004 |
| 200000029645 |
Hybrid application (Article 19(1) of Regulation (EU) 2019/6) |
| 200000029646 |
Hybrid application - change in target species (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000029648 |
Hybrid application - change in withdrawal period (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000029650 |
Hybrid application - other (Article 19(1)(a) of Regulation (EU) 2019/6) |
| 200000029651 |
Full application (Article 8 of Regulation (EU) 2019/6) |
| 200000043394 |
New active substance - Limited Markets (Article 23 of Regulation (EU) 2019/6) |
| 200000043395 |
Known active substance - Limited Markets (Article 23 of Regulation (EU) 2019/6) |
| 200000043396 |
New active substance - Exceptional circumstances (Article 25 of Regulation (EU) 2019/6) |
| 200000043397 |
Known active substance - Exceptional circumstances (Article 25 of Regulation (EU) 2019/6) |